FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps

FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps
The Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters
Reuters
Updated:
0:00

The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic were vulnerable to cyberattacks and that hackers could potentially hamper insulin delivery by accessing the device.

The agency issued a cybersecurity risk alert for the Medtronic MiniMed 600 Series insulin pump system, which has several components including an insulin pump and a blood glucose meter that communicate wirelessly.